Haleon

HLN.L

Tags: GB Healthcare Drug Manufacturers - Specialty & Generic

Haleon plc Price (HLN.L)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

9,263,000,000

(0.2598)%

Market Cap of Haleon (HLN.L)

Market cap:

As of , HLN.L has a market cap of . This makes HLN.L the 24th most valuable company in the GB by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name t... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $308.37-417.7
Market Cap 35.52B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Mr. Brian James McNamara
IPO Date: July, 18, 2022
Country: GB
Currency: GBp
Headquaters: No Data
Employees: 25408

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: